These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Efficacy of systemic phenytoin in the treatment of junctional epidermolysis bullosa. Fine JD; Johnson L Arch Dermatol; 1988 Sep; 124(9):1402-6. PubMed ID: 3415285 [TBL] [Abstract][Full Text] [Related]
4. Cicatricial junctional epidermolysis bullosa. Haber RM; Hanna W; Ramsay CA; Boxall LB J Am Acad Dermatol; 1985 May; 12(5 Pt 1):836-44. PubMed ID: 4008687 [TBL] [Abstract][Full Text] [Related]
5. [Phenytoin therapy in recessive dystrophic epidermolyses (epidermolysis bullosa dystrophica type Hallopeau-Siemens and epidermolysis bullosa dystrophica inversa)]. Wirth H; Nesch A; Ostapowicz B; Anton-Lamprecht I Z Hautkr; 1983 Apr; 58(8):555-74. PubMed ID: 6858283 [TBL] [Abstract][Full Text] [Related]
8. Evaluation and treatment of the newborn with epidermolysis bullosa. Gonzalez ME Semin Perinatol; 2013 Feb; 37(1):32-9. PubMed ID: 23419761 [TBL] [Abstract][Full Text] [Related]
9. Epidermolysis bullosa: a review. Cooper TW; Bauer EA Pediatr Dermatol; 1984 Jan; 1(3):181-8. PubMed ID: 6387664 [TBL] [Abstract][Full Text] [Related]
11. Autosomal recessive epidermolysis bullosa simplex. Generalized phenotypic features suggestive of junctional or dystrophic epidermolysis bullosa, and association with neuromuscular diseases. Fine JD; Stenn J; Johnson L; Wright T; Bock HG; Horiguchi Y Arch Dermatol; 1989 Jul; 125(7):931-8. PubMed ID: 2662909 [TBL] [Abstract][Full Text] [Related]